MEF2C and cancer: Enrichment analysis showed that MEF2C involves the TGFβ signaling pathway, while the study of Travis et al concluded that TGF-β inhibits DC differentiation and activation.[41] Based on these findings, we suggest that MEF2C overexpression may promote TGF-β production and inhibit DC activation, which in turn exerts a pro-cancer effect.